BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6349357)

  • 1. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of serum gentamicin concentrations by a biological method, fluorescence polarization immunoassay and enzyme multiplied immunoassay.
    Araj GF; Khattar MA; Thulesius O; Pazhoor A
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):542-5. PubMed ID: 3536762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three methods for measuring gentamicin and tobramycin in serum.
    Ngui-Yen JH; Hofmann T; Wigmore M; Smith JA
    Antimicrob Agents Chemother; 1981 Dec; 20(6):821-5. PubMed ID: 7034643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an immunoassay and a microbiological assay for tobramycin serum concentrations.
    Fukuchi H; Yoshida M; Okihara M; Tokuoka S; Konishi T
    Am J Hosp Pharm; 1981 Dec; 38(12):1933-6. PubMed ID: 6798863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a fluorescent immunoassay with an enzyme immunoassay and a radioimmunoassay for gentamicin.
    Lau AH; Chow-Tung E
    Am J Hosp Pharm; 1984 Dec; 41(12):2647-50. PubMed ID: 6393760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of storage time at -20 degrees C on the determination of serum concentrations of tobramycin in the presence of 6 beta-lactams].
    Forey F; Coulet M; Freney J; Brun Y; Fleurette J
    Pathol Biol (Paris); 1983 May; 31(5):404-12. PubMed ID: 6353332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the homogeneous substrate-labeled fluorescent immunoassay for tobramycin in serum.
    Belpaire FM; Hallynck T; Pyck J
    Methods Find Exp Clin Pharmacol; 1982; 4(4):249-53. PubMed ID: 6750285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzymatic quick determination of aminoglycoside antibiotics in serum].
    Lode H; Kemmerich B
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):59-64. PubMed ID: 765289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enzyme-multiplied immunoassay technique with fluorescence polarization immunoassay for determination of gentamicin and tobramycin levels in serum.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Clin Microbiol; 1984 Nov; 20(5):866-8. PubMed ID: 6392321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.
    Jolley ME; Stroupe SD; Wang CH; Panas HN; Keegan CL; Schmidt RL; Schwenzer KS
    Clin Chem; 1981 Jul; 27(7):1190-7. PubMed ID: 7016372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four assay methods for determination of tobramycin in human serum.
    Acton WJ; Van Duyn OM; Allen LV; Flournoy DJ
    Clin Chem; 1982 Jan; 28(1):177-80. PubMed ID: 7035000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of time and temperature on inactivation of aminoglycosides by ampicillin at neonatal dosages.
    Daly JS; Dodge RA; Glew RH; Keroack MA; Bednarek FJ; Whalen M
    J Perinatol; 1997; 17(1):42-5. PubMed ID: 9069064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.